VACCINE INSIGHTS

Filter by ContentType

Advanced drying technologies for vaccine products

Advanced drying technologies for vaccine products

Sue Behrens
11 December 2024
Expert Insight
The effects of different causes of immunodeficiency on vaccine efficacy against infectious diseases: some lessons from COVID

The effects of different causes of immunodeficiency on vaccine efficacy against infectious diseases: some lessons from COVID

Jeremy S Brown
10 October 2024
Expert Insight
Advanced technologies enabling accessible and sustainable vaccine development and manufacturing for future pandemics

Advanced technologies enabling accessible and sustainable vaccine development and manufacturing for future pandemics

June Kim, Anna Särnefält
10 October 2024
Expert Insight
Immunity and vaccine development against liver-stage malaria

Immunity and vaccine development against liver-stage malaria

Mitch Ganley, William Heath, Lynette Beattie
28 August 2024
Expert Insight
MHRA regulatory considerations for the quality of mRNA products

MHRA regulatory considerations for the quality of mRNA products

Ka-Wai Wan, Francis Galaway
22 May 2024
Expert Insight
Insights into manufacturing lab-scale in vitro transcribed RNA modalities

Insights into manufacturing lab-scale in vitro transcribed RNA modalities

Andrew Varley
21 May 2024
Expert Insight
Impact of glycosylation of vaccine antigens on quality and performance

Impact of glycosylation of vaccine antigens on quality and performance

John F Cipollo, Diane McCarthy
12 April 2024
Expert Insight
Challenges and advances of the stability of mRNA delivery therapeutics

Challenges and advances of the stability of mRNA delivery therapeutics

Jin Zhai, Trystin Cote, Yupeng Chen
13 March 2024
Expert Insight
RSV vaccines: a new hope but the virus might strike back

RSV vaccines: a new hope but the virus might strike back

J Tregoning, H Li, C Thomas et al
13 March 2024
Expert Insight
PAT to the future: combining in silico tools and analytics for streamlining process development of aluminum-adjuvanted vaccines

PAT to the future: combining in silico tools and analytics for streamlining process development of aluminum-adjuvanted vaccines

Andrea Albano, Angelo Palmese
11 January 2024
Expert Insight
Challenges & opportunities in sterile filtration of vaccines

Challenges & opportunities in sterile filtration of vaccines

K Messerian, Z Du, N Taylor et al
20 December 2023
Expert Insight
Risk-based approach to leverage prior knowledge & statistical modeling during process development & process characterization of multivalent vaccines

Risk-based approach to leverage prior knowledge & statistical modeling during process development & process characterization of multivalent vaccines

B Carrillo Conde, E Rainbolt , A Cheng et al
25 October 2023
Expert Insight
Non-mucosal vaccination strategies to enhance mucosal immunity

Non-mucosal vaccination strategies to enhance mucosal immunity

Lisa A Morici, James B McLachlan
13 July 2023
Expert Insight
MVA-vectored universal beta-coronavirus vaccine design & development

MVA-vectored universal beta-coronavirus vaccine design & development

M J Newman, M J Hauser, A Domi et al
28 June 2023
Expert Insight
Development of recombinant vesicular stomatitis virus vaccine platform for rapid response to Ebola and COVID-19 outbreaks

Development of recombinant vesicular stomatitis virus vaccine platform for rapid response to Ebola and COVID-19 outbreaks

C Ton, M A Winters, R Ducoat et al
13 June 2023
Expert Insight
Resolving facility design conflicts between biocontainment & good manufacturing practices for vaccines manufacture

Resolving facility design conflicts between biocontainment & good manufacturing practices for vaccines manufacture

Faye Litherland, Ranna Eardley-Patel
02 May 2023
Expert Insight
Stability assessment for vaccines: recent trends & learnings from accelerated scenarios

Stability assessment for vaccines: recent trends & learnings from accelerated scenarios

Cristiana Campa
10 November 2022
Expert Insight
Considerations for the stability of vaccines as liquid-, frozen-, or lyophilized presentations

Considerations for the stability of vaccines as liquid-, frozen-, or lyophilized presentations

Ramin Sabet Azad, Raafat Fahim
13 October 2022
Expert Insight
A blueprint for quality by digital design to support rapid RNA vaccine process development, manufacturing & supply

A blueprint for quality by digital design to support rapid RNA vaccine process development, manufacturing & supply

S Daniel, Z Kis, C Kontoravdi et al
22 September 2022
Expert Insight
The quest for vaccine-induced immune correlates of protection against tuberculosis

The quest for vaccine-induced immune correlates of protection against tuberculosis

E Nemes, A Fiore-Gartland, C Boggiano et al
30 July 2022
Expert Insight
Opportunities & challenges of applying AI/ML to integrating systems vaccinology studies

Opportunities & challenges of applying AI/ML to integrating systems vaccinology studies

Robert A. van den Berg, Vanesa Bol
23 July 2022
Expert Insight